PCIB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PCI Biotech Holding ASA

Watchlist Manager

Watchlist

Price: 0.07 NOK -39.13% Market Closed

Market Cap: kr4.3m

	PCI Biotech Holding ASA OSE:PCIB	NO
	Sodexo SA OTC:SDXAY	FR
G	Gungnir Resources Inc OTC:ASWRF	CA

Profitability Summary

PCI Biotech Holding ASA's profitability score is 8/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-461%

Negative 3Y Average Operating Margin

-487%

Operating Margin is Increasing

-1 100% > -461%

Negative Net Margin

-438%

Negative 3Y Average Net Margin

-448%

Net Margin is Increasing

-1 043% > -438%

Negative Free Cash Flow Margin

-351%

Negative 3Y Average Free Cash Flow Margin

-321%

Free Cash Flow Margin is Increasing

-1 079% > -351%

Negative ROE

-92%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-591%

Declining ROIC

-383% > -442%

View All

Hide

Collapse

8 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.